Short Interest in Mannatech, Incorporated (NASDAQ:MTEX) Decreases By 27.2%

Mannatech, Incorporated (NASDAQ:MTEX) saw a significant decline in short interest in the month of January. As of January 15th, there was short interest totaling 17,947 shares, a decline of 27.2% from the December 31st total of 24,659 shares. Based on an average trading volume of 48,014 shares, the short-interest ratio is presently 0.4 days. Approximately 1.6% of the shares of the company are short sold. Approximately 1.6% of the shares of the company are short sold. Based on an average trading volume of 48,014 shares, the short-interest ratio is presently 0.4 days.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Mannatech in a research report on Monday, December 22nd. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has an average rating of “Sell”.

Mannatech Stock Performance

Mannatech stock traded up $0.20 during midday trading on Monday, reaching $7.65. 30,747 shares of the stock traded hands, compared to its average volume of 31,070. The company has a current ratio of 1.13, a quick ratio of 0.56 and a debt-to-equity ratio of 0.48. The firm has a fifty day moving average price of $8.33 and a two-hundred day moving average price of $8.71. The firm has a market cap of $14.54 million, a price-to-earnings ratio of -8.90 and a beta of 0.79. Mannatech has a fifty-two week low of $6.90 and a fifty-two week high of $13.25.

Mannatech (NASDAQ:MTEX) last announced its quarterly earnings results on Wednesday, November 12th. The company reported $1.01 EPS for the quarter. The company had revenue of $29.16 million for the quarter. Mannatech had a negative net margin of 1.50% and a negative return on equity of 22.75%.

Mannatech Company Profile

Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.

The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.